Five-membered iminocyclitol a-glucosidase inhibitors: Synthetic,biological screening and in silico studies
| dc.contributor.author | Guerreiro, L | |
| dc.contributor.author | Carreiro, E | |
| dc.contributor.author | Fernandes, L | |
| dc.contributor.author | Cardote, T | |
| dc.contributor.author | Moreira, R | |
| dc.contributor.author | Caldeira, A Teresa | |
| dc.contributor.author | Guedes, R | |
| dc.contributor.author | Burke, A J | |
| dc.date.accessioned | 2014-01-29T15:04:54Z | |
| dc.date.available | 2014-01-29T15:04:54Z | |
| dc.date.issued | 2013 | |
| dc.description.abstract | The design and synthesis of a small library of pyrrolidine iminocyclitol inhibitors with a structural similarity to 1,4-dideoxy-1,4-imino-D-arabitol (DAB-1) is reported. This library was specifically designed to gain a better insight into the mechanism of inhibition of glycosidases by polyhydroxylated pyrrolidines or iminocyclitols. Pyrrolidine-3,4-diol 15a and pyrrolidine-3,4-diol diacetate 15b had emerged as the most potent a-glucosidase inhibitors in the series. Docking studies performed with an homology model of a-glucosidase disclosed binding poses for compounds 15a, 15b, 16a, and 16a0 occupying the same region as the NH group of the terminal ring of acarbose and suggest a closer and stronger binding of compound 15a and 15b with the enzyme active site residues. Our studies indicate that 2 or 5-hydroxyl substituents appear to be vital for high inhibitory activity. | por |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | atc@uevora.pt | |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | nd | |
| dc.identifier.citation | Luis R. Guerreiro, Elisabete P. Carreiro, Luis Fernandes , Teresa A. F. Cardote , Rui Moreira ,Ana T. Caldeira, Rita C. Guedes, A. J. Burke (2013). Five-membered iminocyclitol α-glucosidase inhibitors: Synthetic, biological screening and in silico studies. Bioorganic & Medicinal Chemistry. DOI.10.1016/j.bmc.2013.01.030 | por |
| dc.identifier.doi | 10.1016/j.bmc.2013.01.030 | |
| dc.identifier.scientificarea | 303 | por |
| dc.identifier.uri | http://hdl.handle.net/10174/10266 | |
| dc.language.iso | eng | por |
| dc.peerreviewed | yes | por |
| dc.publisher | Elsevier | por |
| dc.rights | openAccess | por |
| dc.subject | Iminocyclitol | por |
| dc.subject | Small molecule inhibitor | por |
| dc.subject | a-Glucosidase | por |
| dc.subject | Enantiopure compound | por |
| dc.subject | (3,4)-Dihydroxypyrrolidine | por |
| dc.title | Five-membered iminocyclitol a-glucosidase inhibitors: Synthetic,biological screening and in silico studies | por |
| dc.type | article | por |